ftInvstr
COHANCE · Healthcare ₹443.5 +0.34% Mkt Cap ₹17058 Cr

COHANCE

Healthcare Drug Manufacturers - Specialty & Generic
₹443.5
+0.34% today · 30d +0.16%
as of 2026-11-09
Price · Daily Candles
AI narrative is temporarily unavailable for COHANCE. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-06-30
REVENUE
₹422 Cr
-23.13% YoY
NET PROFIT
₹-45 Cr
-197.39% YoY
OPM
3.09%
-19.31pp YoY
EPS
₹-0.63
PE 390.0
Intrinsic value · DCF: N/A — ML model predicts severe Δ FCF compression (h1=-50.0%, h2=-34.4%, h3=-34.6% of mktcap), driving projected FCF negative by year 3 despite healthy current FCF. Treating as forecast outlier rather than reporting a misleading ₹0 valuation. Use the Strategy Fit and ML sections instead.
◇ Sector Position
PEERPEROCE %
COHANCE390.08.0
SUNPHARMA37.7921.44
DIVISLAB93.121.56
ZYDUSLIFE28.424.22
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
41
SCORE / 100
Overall
6-axis composite of the sections below.
Performance UNDERPERFORMER 5
Valuation STRETCHED 5
Growth STEADY 57
Profitability AVERAGE 45
Technicals WEAK 45
Risk LOW 90
Key Stats
TTM PE
390.0
P/B
4.54
52W HIGH
₹903.4
OFF HIGH
-50.91%
DIV YIELD
0.0%
MKT CAP
₹17058 Cr
◉ Active Signals
MACDBearish-2.494
RSI(14)Neutral46.47
Street Consensus
10 analysts
₹511.5
mean target
Low ₹315.0Now ₹443.5High ₹1150.0
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold COHANCE and at what entry.

Sign up freeSign in